Imugene Stock Quote IMUND - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

Bid

Ask

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Previous Close

Open

Last Trade

Last Trade Time

Average Volume (3m)

Financial Volume

VWAP

Biostax Corp Announces the Passing of Esteemed Director, H. Louis Salomonsky

Orlando, FL, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing...

Biostax Corp. Signs Collaboration Agreement with Immgenuity, Inc. to Pursue Remission in HIV

Orlando, FL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine, announces the signing of a...

Biostax Corp Announces the FDAs Acceptance of Three Investigational New Drug Applications (IND) Transfers for JKB-122 for the Treatment of NASH, NAFLD and AIH

Orlando, FL, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) ("Biostax"), a hub-and-spoke biotech development engine, announces that they have...

Biostax Corp. and Statera Biopharma, Inc. reach mutually beneficial dispute settlement and amended license agreement providing clearer clinical and commercial pathways for both companies

Orlando, FL, April 20, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. d/b/a Biostax Corp. (OTC Pink: IMUN) (“Biostax”), a hub-and-spoke biotech development engine and Statera Biopharma...

Immune Therapeutics, Inc. Announces Shareholder Approval of Name Change to Biostax Corp. and Unveils New Website, Business Strategies and Direction

ORLANDO, March 01, 2023 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC Pink: IMUN) ("Immune" or "IMUN"), a specialty pharmaceutical company involved in the acquisition, development and...

Immune Therapeutics, Inc. Announces Management Change; Moves Forward with Repositioning Strategy and Long-acting TLR4 (Toll Like Receptor 4) Antagonist JKB-122 Development

Orlando, FL, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Immune Therapeutics, Inc. (OTC PINK:IMUN) (“Immune” or “IMUN”) today announced that its Chief Executive Officer, President, and Director, Stephen...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MTHOMithril Silver and Gold Ltd	AUD 0.16 (135.29%)	1.36M
MTHMithril Silver and Gold Ltd	AUD 0.36 (75.61%)	15.73M
TX3Trinex Minerals Ltd	AUD 0.003 (50.00%)	75k
SMSStar Minerals Limited	AUD 0.049 (48.48%)	1.97M
BGEBridge SaaS Ltd	AUD 0.014 (40.00%)	250k
SMXSecurity Matters Limited	AUD 0.03 (-88.46%)	1.27M
NTIOANeurotech International Limited	AUD 0.003 (-40.00%)	271.81k
HZROHazer Group Limited	AUD 0.02 (-33.33%)	5.46k
TMGODTrigg Minerals Ltd	AUD 0.004 (-33.33%)	7.44M
RBRRBR Group Limited	AUD 0.0015 (-25.00%)	8.25M
RSGResolute Mining Limited	AUD 0.71 (-3.73%)	172.2M
REDRed 5 Limited	AUD 0.335 (1.52%)	134.21M
CXOCore Lithium Ltd	AUD 0.105 (5.00%)	108.2M
STXStrike Energy Limited	AUD 0.22 (-2.22%)	101.35M
SPRSpartan Resources Limited	AUD 1.36 (3.42%)	77.15M